BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 29, 2007
View Archived Issues
Effect of paliperidone on QTc interval not clinically relevant
Read More
New anti-HCV drugs described in recent Bayer patent
Read More
New agents for inflammatory disorders reported in recent patents
Read More
AGI-003 effective in non-constipated irritable bowel syndrome
Read More
Three-year results show benefit of alemtuzumab treatment for multiple sclerosis
Read More
STEALTH I, BEACON and CREATE trials show positive results for BioMatrix and Excel
Read More
Combination therapy with quetiapine effective in bipolar disorder
Read More
Recent patents disclose novel analgesic agents
Read More
Marillion initiates phase I human clinical trial for anticancer drug MN-201
Read More
Vitor will undergo pilot phase III trial in order to finalize special protocol assessment
Read More
NPS Pharmaceuticals receives Japanese approval for cinacalcet hydrochloride
Read More
Positive results from phase II clinical trial of Anthera's A-002 for cardiovascular disease
Read More
Primary endpoint met in phase III Treanda trial for indolent NHL
Read More
Statistical significance in primary endpoints reported for EVT-201 in phase II
Read More
First human DISP1 gene mutation in a patient with congenital diaphragmatic hernia
Read More
In vivo efficacy of cell adhesion inhibitor K-13182 in Sjogren's syndrome mouse model
Read More
New ghrelin receptor antagonists with potential for the treatment of diabetes and obesity
Read More
Tolerx forms alliance with GlaxoSmithKline to develop and commercialize TRX-4
Read More
Daiichi Sankyo and Lilly suspend two phase II trials of antiplatelet agent prasugrel
Read More
Argenta extends integrated contract drug discovery agreement with Genentech
Read More
Ipsat reveals positive results from phase IIb study of Ipsat P1A
Read More
Galapagos and Janssen enter into global alliance on rheumatoid arthritis research
Read More
Yale Cancer Center begins clinical trial of Marshall Edwards' oral phenoxodiol
Read More
Gene expression patterns in white blood cells associated with multiple sclerosis are identified
Read More
Omrix initiates phase I/II clinical trial of Adhexil in gynecological surgery of the ovaries
Read More
Callisto initiates phase II extension trial of atiprimod for neuroendocrine cancer
Read More
Osiris begins phase II study of Prochymal for type 1 diabetes
Read More
Haemacure adopts new two-phase strategy in clinical trials for Hemaseel HMN
Read More
